We are live on ! Find out more
LWCFA

Loring Wolcott & Coolidge Fiduciary Advisors Portfolio holdings

AUM $10.3B
1-Year Est. Return 3.26%
This Fund
S&P 500
This Quarter Est. Return
-2.2%
1 Year Est. Return
+3.26%
3 Year Est. Return
+43.63%
5 Year Est. Return
+56.22%
10 Year Est. Return
+342.64%
AUM
$8.93B
AUM Growth
-$427M
Cap. Flow
-$6.66M
Cap. Flow %
-0.07%
Top 10 Hldgs %
46.19%
Holding
665
New
38
Increased
95
Reduced
216
Closed
58

Top Buys

Rank Stock Value
1
VLTO icon
Veralto
VLTO
+$53.6M
2
PAYC icon
Paycom
PAYC
+$43.1M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$21.4M
4
FDS icon
Factset
FDS
+$15.8M
5
VEEV icon
Veeva Systems
VEEV
+$13.5M

Top Sells

Rank Stock Value
1
EW icon
Edwards Lifesciences
EW
+$33.8M
2
IQV icon
IQVIA
IQV
+$17.1M
3
MA icon
Mastercard
MA
+$13M
4
DIS icon
Walt Disney
DIS
+$10.7M
5
PYPL icon
PayPal
PYPL
+$10.1M

Sector Composition

Rank Sector Weight
1 Technology 38.33%
2 Healthcare 16.32%
3 Consumer Discretionary 10.8%
4 Financials 10.77%
5 Communication Services 6.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VTR icon
476
Ventas
VTR
$46.3B
$22K ﹤0.01%
500
LBRDA icon
477
Liberty Broadband Class A
LBRDA
$5.19B
$21.9K ﹤0.01%
256
NWL icon
478
Newell Brands
NWL
$2.62B
$21.7K ﹤0.01%
3,184
BIDU icon
479
Baidu
BIDU
$35.4B
$21.4K ﹤0.01%
200
LLYVK icon
480
Liberty Live Group Series C
LLYVK
$9.91B
$21.4K ﹤0.01%
+642
New +$21.3K
WAB icon
481
Wabtec
WAB
$50B
$20.9K ﹤0.01%
191
-133
-41% -$14.8K
AZN icon
482
AstraZeneca
AZN
$245B
$20.4K ﹤0.01%
159
CSL icon
483
Carlisle Companies
CSL
$14.8B
$20.3K ﹤0.01%
77
BKH icon
484
Black Hills Corp
BKH
$5.64B
$20K ﹤0.01%
400
VSTM icon
485
Verastem
VSTM
$615M
$19K ﹤0.01%
2,949
MBB icon
486
iShares MBS ETF
MBB
$39.2B
$18.8K ﹤0.01%
+214
New +$19.6K
ICE icon
487
Intercontinental Exchange
ICE
$85.5B
$18.8K ﹤0.01%
177
EPAM icon
488
EPAM Systems
EPAM
$5.13B
$18.6K ﹤0.01%
80
SPOT icon
489
Spotify
SPOT
$102B
$18.4K ﹤0.01%
110
WASH icon
490
Washington Trust Bancorp
WASH
$765M
$18.2K ﹤0.01%
739
-180
-20% -$5.14K
HBAN icon
491
Huntington Bancshares
HBAN
$36.1B
$18.1K ﹤0.01%
1,750
RIG icon
492
Transocean
RIG
$6.38B
$17.9K ﹤0.01%
2,592
BNTX icon
493
BioNTech
BNTX
$23.3B
$17.6K ﹤0.01%
+190
New +$21K
SE icon
494
Sea Limited
SE
$75.5B
$17.1K ﹤0.01%
414
-4,120
-91% -$201K
AAXJ icon
495
iShares MSCI All Country Asia ex Japan ETF
AAXJ
$3.86B
$17K ﹤0.01%
271
EEM icon
496
iShares MSCI Emerging Markets ETF
EEM
$30.6B
$17K ﹤0.01%
450
CDZI icon
497
Cadiz
CDZI
$298M
$16.2K ﹤0.01%
5,000
FMS icon
498
Fresenius Medical Care
FMS
$12.6B
$16K ﹤0.01%
926
EGP icon
499
EastGroup Properties
EGP
$11B
$15.9K ﹤0.01%
94
WTS icon
500
Watts Water Technologies
WTS
$12.8B
$15.6K ﹤0.01%
84

Similar funds

Loring Wolcott & Coolidge Fiduciary Advisors's Q3 2023 Portfolio in Review

As of Q3 2023, Loring Wolcott & Coolidge Fiduciary Advisors held 665 positions worth $8.93B, down 4.6% from $9.36B the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Loring Wolcott & Coolidge Fiduciary Advisors's Q3 2023 filing shows 38 new, 95 increased, 216 reduced and 58 closed positions. Its largest new stake was Veralto: 643,236 shares worth $45.2M. The largest sale was Edwards Lifesciences, an estimated $33.8M.

By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 38% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Loring Wolcott & Coolidge Fiduciary Advisors's largest Q3 2023 buy was Veralto: 643,236 shares worth $45.2M.
  • Loring Wolcott & Coolidge Fiduciary Advisors added most to Paycom in Q3 2023, an estimated $43.1M increase.
  • Loring Wolcott & Coolidge Fiduciary Advisors's biggest Q3 2023 reduction was Edwards Lifesciences, cutting an estimated $33.8M.
  • Loring Wolcott & Coolidge Fiduciary Advisors fully exited iShares 1-3 Year Treasury Bond ETF in Q3 2023, selling an estimated $574K.
  • Loring Wolcott & Coolidge Fiduciary Advisors's ten largest holdings make up 46% of its $8.93B portfolio in Q3 2023.
  • Loring Wolcott & Coolidge Fiduciary Advisors opened 38 new positions and closed 58 in Q3 2023.
  • Loring Wolcott & Coolidge Fiduciary Advisors's portfolio value fell 4.6% quarter-over-quarter to $8.93B.

Based on Loring Wolcott & Coolidge Fiduciary Advisors's 13F filing for Q3 2023, filed 3 Nov 2023.